Keyword: Bavarian Nordic

Several of GlaxoSmithKline's vaccines are riding strong momentum and now the drugmaker is selling two assets to focus on those growth products.

After working with the government for years to advance a next-gen smallpox vaccine, Bavarian Nordic has finally scored its approval.

Here is some other vaccine news of note for the week.

Here is some other vaccine news of note for the week.

Bavarian Nordic is building a new fill-finish manufacturing line in Denmark to bring Imvamune manufacturing in-house.

Initial lab work suggests that the Ebola Zaire strain—the one targeted by Merck's rVSV-ZEBOV—is likely the cause of this outbreak.

Here is some other vaccine news of note for the week.

Here is some other vaccine news of note for the week.

BN will use its proprietary MVA-BN platform to develop a vaccine against three strains of the potentially deadly mosquito-borne virus.

Here's some other vaccine news of note for the week.